EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Use of extracorporeal hemoperfusion therapy in an adult horse with Clostridioides difficile colitis and severe systemic inflammatory response syndrome

Kallie J Hobbs iD, Andre N V Le Sueur iD, Kimberly Hallowell iD, Emily Martin, Mary Katherine Sheats iD, Yu Ueda iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17154 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Kallie J Hobbs und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Horse Diseases, Hemoperfusion, Systemic Inflammatory Response Syndrome, Clostridioides difficile. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIH T-32, ORIP NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An 8-year-old American Quarter Horse gelding was treated with extracorporeal hemoperfusion (HP) therapy for treatment of Clostridioides difficile (C. difficile) colitis-induced systemic inflammatory response syndrome (SIRS). The gelding developed C. difficile associated peracute colitis and severe SIRS as evidenced by a positive fecal C. difficile PCR and tachypnea, tachycardia, fever, neutropenia, altered mucous membrane color, and hyperlactatemia. Concurrent acute kidney injury in the horse limited the use of routine anti-inflammatory and anti-lipopolysaccharide treatments, including flunixin meglumine and polymyxin B, because of potential for nephrosis. Extracorporeal HP therapy was performed twice within 48 hours of the onset of severe SIRS during which the horse's physical examination variables stabilized. The horse was euthanized after 4 days because of laminitis. These findings support further investigation of extracorporeal HP therapy as an adjunctive treatment for severe SIRS/sepsis in horses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Horse DiseasesHemoperfusionSystemic Inflammatory Response SyndromeClostridioides difficileClostridium InfectionsAnimalsHorsesMaleColitis

Stichwörter der Autor:innen

cytokinesequinehemodialysishemoperfusionimmunologyrenal/urinary tract

Autor:innen und Institutionen

  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Kallie J Hobbs, Andre N V Le Sueur, Kimberly Hallowell, Mary Katherine Sheats, Yu Ueda

Förderung

  • NIH HHS
  • NIH T-32
  • ORIP NIH HHS
  • U.S. Department of Health and Human Services
  • Office of Research Infrastructure Programs
  • National Institutes of Health

Zitieren

APA

Hobbs, K. J., Le Sueur, A. N. V., Hallowell, K., Martin, E., Sheats, M. K., & Ueda, Y. (2024). Use of extracorporeal hemoperfusion therapy in an adult horse with Clostridioides difficile colitis and severe systemic inflammatory response syndrome. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17154

Vancouver

Hobbs KJ, Le Sueur ANV, Hallowell K, Martin E, Sheats MK, Ueda Y. Use of extracorporeal hemoperfusion therapy in an adult horse with Clostridioides difficile colitis and severe systemic inflammatory response syndrome. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17154

BibTeX
@article{Hobbs2024,
  author = {Hobbs, Kallie J and Le Sueur, Andre N V and Hallowell, Kimberly and Martin, Emily and Sheats, Mary Katherine and Ueda, Yu},
  title = {Use of extracorporeal hemoperfusion therapy in an adult horse with Clostridioides difficile colitis and severe systemic inflammatory response syndrome},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17154}
}
Kostenlos starten →